CCR6 and hepatocellular carcinoma: In contrast to the above observations, TH22 cells that express CCR6 promote and support the progression of colon, pancreatic, and hepatocellular carcinomas, as also evidenced by pro-tumorigenic IL-22 in two murine colon tumor models.